Montserrat Tech Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montserrat Tech Update.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 25, 2026

Mar. 25, 2026

WidePoint Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 25, 2026

Outlook Therapeutics Announces Closing of $5.0 Million Public Offering

GlobeNewswire

Mar. 25, 2026

Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

GlobeNewswire

Mar. 25, 2026

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

GlobeNewswire

Mar. 25, 2026

Rigetti Computing Intends to Invest $100 Million in UK to Accelerate Quantum Computing Development

GlobeNewswire

Mar. 25, 2026

Orezone Gold Completes Strategic Acquisition of Casa Berardi Gold Mine and Quebec Exploration Portfolio

GlobeNewswire

Mar. 25, 2026

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

GlobeNewswire

Mar. 25, 2026

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

GlobeNewswire

Mar. 25, 2026

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

Mar. 25, 2026

Finland Is Scrapping Its Online Gambling Monopoly. Here's What Comes Next

GlobeNewswire

Mar. 25, 2026

GloraMD Liquid Solution: A New Approach to Smoother, Firmer-Looking Skin with Glora MD Serum

GlobeNewswire

Mar. 25, 2026

Cloudera Announces 2026 Global Partner Awards Winners at IMPACT26

GlobeNewswire

Mar. 25, 2026

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

Mar. 25, 2026

Lightfield Launches One-Hour CRM Migration Agent, Enabling Startups to Replace HubSpot With an AI-Native CRM in Under 60 Minutes

GlobeNewswire

Mar. 25, 2026

IP Strategy Highlights Tokenized K-Culture IP Distribution via WAVIST on Story

GlobeNewswire

Mar. 25, 2026

Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration

GlobeNewswire

Mar. 25, 2026

Approaching.ai Brings in Top Scientists to Capture AI’s Inference Boom

GlobeNewswire

Mar. 25, 2026

Mansory Partners with LUKSO to Bring Luxury Automotive Culture Onchain with Universal Profiles

GlobeNewswire

Mar. 25, 2026

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

GlobeNewswire

Mar. 25, 2026

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

GlobeNewswire